Related to Pfizer and Crown Team Up to Develop Treatments for Asian Cancers

• Pfizer Taps Sutro to Develop Peptide-Based Therapeutics
  
• Qiagen Sets Up Subsidiary in India as Part of Asian Expansion Effort
  
• Pfizer and Takeda Ink Co-Promotion Deal for Late-Stage RA Therapy
  
• Charles River to Distribute Pfizer Research Models
  
• Pfizer to Attack Lysosomal Storage Diseases with Zacharon’s Small Molecule Approach
  
• Phase III Failure Leads Medivation and Pfizer to Ditch Dimebon for Huntington Disease
  
• Pfizer’s Neusentis Partners with Cellzome on Stem Cell Epigenetics Research
  
• Pfizer Selects Parexel and Icon to Implement and Manage Clinical Trials
  
• Pfizer Gains Patent from Cell Signaling Technology to Enhance Companion Diagnostic Efforts
  
• Aslan Pharmaceuticals Licenses Array’s Phase II-Stage Solid Tumor Candidate
  
• Pfizer Establishes Center for Therapeutic Innovation Partnership with UC San Diego
  
• Pfizer Allies with Qiagen to Develop Companion Diagnostic for NSCLC Drug Candidate
  
• Merck Serono Opens Biomarker R&D Lab at Pharmaron’s Facility in Beijing
  
• Puma Acquires Global Rights to Pfizer’s Phase III Breast Cancer Drug Neratinib
  
• AKP Pays Zosano $7.5M as Part of Asian Agreement for Transdermal Parathyroid Hormone Patch
  
• Pfizer Negotiates Global Rights to GlycoMimetics’ Phase II Sickle Cell Crisis Drug
  
• Pfizer Returns Two Early-Stage Anti-TNF-Alpha Nanobodies to Ablynx
  
• Children's Hospital Boston and Pfizer Join Forces Against Duchenne Muscular Dystrophy
  
• Pfizer, Karo Bio Ally for Autoimmune Diseases
  
• U.K.’s Technology Strategy Board Awards £900K to Stem Cell Research Consortium